Capturing public interest toward new tools for controlling human immunodeficiency virus (HIV) infection exploiting data from Google Trends

Health Informatics Journal

Volumn 25, Issue 4, 2019, Pages 1383-1397

  Mahroum, Naim ^a,d   Bragazzi, Nicola Luigi ^b   Brigo, Francesco ^c   Waknin, Roy ^d   Sharif, Kassem ^e   Mahagna, Hussein ^e   Amital, Howard ^e   Watad, Abdulla ^a,d  

^a SHEBA MEDICAL CENTER   (Israel)

^b UNIVERSITY OF GENOA   (Italy)

^c UNIVERSITY OF VERONA   (Italy)

^d TEL AVIV UNIVERSITY   (Israel)

^e NONE

Author keywords

acquired immune deficiency syndrome; Google Trends; human immunodeficiency virus; Truvada; vaccination; web search

Indexed keywords

DEVICES; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PATHOGENICITY; PSYCHOLOGY; PUBLIC OPINION; SOCIAL MEDIA;

HIV INFECTIONS; HIV-1; HUMANS; PUBLIC OPINION; SOCIAL MEDIA;

EID: 85045261346     PISSN: 14604582     EISSN: 17412811     Source Type: Journal    
DOI: 10.1177/1460458218766573     Document Type: Article

References (40)

1. Mariner WK, Gallo RC. Getting to market: the scientific and legal climate for developing an AIDS vaccine. Law Med Health Care 1987; 15(1–2): 17–26.
2. Girard MP, Osmanov SK, Kieny MP. A review of vaccine research and development: the human immunodeficiency virus (HIV). Vaccine 2006; 24(19): 4062–4081.
3. Johnston MI, Fauci AS. An HIV vaccine—evolving concepts. N Engl J Med 2007; 356(20): 2073–2081.
4. Mills E, Cooper C, Guyatt G,. Barriers to participating in an HIV vaccine trial: a systematic review. AIDS 2004; 18(17): 2235–2242.
5. Newman PA, Logie C. HIV vaccine acceptability: a systematic review and meta-analysis. AIDS 2010; 24(11): 1749–1756.
6. Hammer SM, Squires KE, Hughes MD,. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. N Engl J Med 1997; 337(11): 725–733.
7. Grant RM, Lama JR, Anderson PL,. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med 2010; 363(27): 2587–2599.
8. Breeze S. FDA PrEPares to reduce risk of HIV infection with Truvada®. Expert Rev Clin Phar 2012; 5(5): 499.
9. Molina JM, Capitant C, Spire B,. On-demand preexposure prophylaxis in men at high risk for HIV-1 infection. N Engl J Med 2015; 373(23): 2237–2246.
10. McCormack S, Dunn DT, Desai M,. Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial. Lancet 2016; 387(10013): 53–60.
11. Nuti SV, Wayda B, Ranasinghe I,. The use of Google Trends in health care research: a systematic review. PLoS ONE 2014; 9(10): e109583.
12. Wang Z, Chakraborty P, Mekaru SR,. Dynamic Poisson autoregression for influenza-like-illness case count prediction. In: Proceedings of the 21th ACM SIGKDD international conference on knowledge discovery and data mining, Sydney, NSW, Australia, 10–13 August 2015, pp. 1285–1294. New York: ACM.
13. Orellano PW, Reynoso JI, Antman J,. Using Google Trends to estimate the incidence of influenza-like illness in Argentina. Cad Saude Publica 2015; 31(4): 691–700.
14. Domnich A, Arbuzova EK, Signori A,. Demand-based web surveillance of sexually transmitted infections in Russia. Int J Public Health 2014; 59(5): 841–849.
15. Roadknight C, Marshall I, Bilchev G. Network performance implications of variability in data traffic. BT Technol J 2000; 18(2): 151–158.
16. Mackay TD, Baker RGV. Classifying Internet traffic using linear regression. In: Computational science and its applications—ICCSA 2005: international conference (ed Gervasi O, Gavrilova ML, Kumar V,.), Singapore, 9–12 May 2005, Proceedings, Part III, pp. 143–151. Berlin: Springer.
17. Pollett S, Wood N, Boscardin WJ,. Validating the use of Google Trends to enhance pertussis surveillance in California. PLoS Currents 2015; 7, doi: 10.1371/currents.outbreaks.7119696b3e7523faa4543faac87c56c2.
18. Gross N, Mann M. Is there a “Ferguson effect?” Google searches, concern about police violence, and crime in U.S. cities, 2014–2016. Socius 2017; 3: 2378023117703122.
19. van Gelder P, Beijer G, Berger M, (eds). Statistical analysis of pageviews on web sites. Southampton: WIT Press, 2002.
20. Tierney HLR, Pan B. A Poisson regression examination of the relationship between website traffic and search engine queries. NETNOMICS Econ Res Electron Netw 2012; 13(3): 155–189.
21. Pervaiz F, Pervaiz M, Abdur Rehman N,. FluBreaks: early epidemic detection from Google flu trends. J Med Internet Res 2012; 14(5): e125.
22. Eysenbach G. Infodemiology and infoveillance tracking online health information and cyberbehavior for public health. Am J Prev Med 2011; 40(5 Suppl. 2): S154–S158.
23. Alicino C, Bragazzi NL, Faccio V,. Assessing Ebola-related web search behaviour: insights and implications from an analytical study of Google Trends-based query volumes. Infect Dis Poverty 2015; 4: 54.
24. Carter M. How Twitter may have helped Nigeria contain Ebola. BMJ 2014; 349: g6946.
25. Chiu APY, Lin Q, He D. News trends and web search query of HIV/AIDS in Hong Kong. PLoS ONE 2017; 12(9): e0185004.
26. Ling R, Lee J. Disease monitoring and health campaign evaluation using Google search activities for HIV and AIDS, stroke, colorectal cancer, and marijuana use in Canada: a retrospective observational study. JMIR Public Health Surveill 2016; 2(2): e156.
27. Buchbinder SP, Mehrotra DV, Duerr A,. Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial. Lancet 2008; 372(9653): 1881–1893.
28. Rerks-Ngarm S, Pitisuttithum P, Nitayaphan S,. Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. N Engl J Med 2009; 361(23): 2209–2220.
29. Choi E, Michalski CJ, Choo SH,. First Phase I human clinical trial of a killed whole-HIV-1 vaccine: demonstration of its safety and enhancement of anti-HIV antibody responses. Retrovirology 2016; 13(1): 82.
30. UNAIDS. Countries, 2017, http://www.unaids.org/en/regionscountries/countries
31. InternetWorldStats, 2017, http://www.internetworldstats.com/africa
32. Lippi G, Mattiuzzi C, Cervellin G,. Direct oral anticoagulants: analysis of worldwide use and popularity using Google Trends. Ann Transl Med 2017; 5(16): 322.
33. Seifter A, Schwarzwalder A, Geis K,. The utility of “Google Trends” for epidemiological research: Lyme disease as an example. Geospatial Health 2010; 4(2): 135–137.
34. Bragazzi NL, Alicino C, Trucchi C,. Global reaction to the recent outbreaks of Zika virus: insights from a Big Data analysis. PLoS ONE 2017; 12(9): e0185263.
35. Vlahov D, Astemborski J, Solomon L,. Interest in HIV vaccines among injection drug users in Baltimore, Maryland. AIDS Res Hum Retrov 1994; 10(Suppl. 2): S265–S268.
36. Koblin BA, Avrett S, Taylor PE,. Willingness to participate in HIV-1 vaccine efficacy trials and the effect of media events among gay and bisexual men in New York City: Project ACHIEVE. J Acq Immun Def Synd 1997; 15(2): 165–171.
37. Segev E, Baram-Tsabari A. Seeking science information online: data mining Google to better understand the roles of the media and the education system. Public Underst Sci 2012; 21(7): 813–829.
38. Rosselli R, Martini M, Bragazzi NL,. The public health impact of the so-called “Fluad Effect” on the 2014/2015 influenza vaccination campaign in Italy: ethical implications for health-care workers and health communication practitioners. Adv Exp Med Biol 2017; 973: 125–134.
39. Gargano LM, Underwood NL, Sales JM,. Influence of sources of information about influenza vaccine on parental attitudes and adolescent vaccine receipt. Hum Vacc Immunother 2015; 11(7): 1641–1647.
40. Odone A, Chiesa V, Ciorba V,. Influenza and immunization: a quantitative study of media coverage in the season of the “Fluad case.” Epidemiol Prev 2015; 39(4 Suppl. 1): 139–145.